BLAZE-1: COVID-19 Neutralizing Antibody (Bamlanivimab)
Background: Throughout the COVID19 pandemic, massive efforts have been invested on the research of effective therapeutics. Much of the research looks at repurposing older treatments (i.e. antimalarial drugs, antiviral agents, interleukin blockers and convalescent plasma therapy). There have been no …